Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological Characteristics and Mutations Driving Development of Early Lung Adenocarcinoma: Tumor Initiation and Progression
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 4, Pages 1259
Publisher
MDPI AG
Online
2018-04-24
DOI
10.3390/ijms19041259
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ
- (2017) Xuan Xu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A Braf kinase-inactive mutant induces lung adenocarcinoma
- (2017) Patricia Nieto et al. NATURE
- Molecular genetics and cellular events of K-Ras-driven tumorigenesis
- (2017) G G Jinesh et al. ONCOGENE
- Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
- (2017) Kentaro Inamura Frontiers in Oncology
- Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma
- (2016) Madhusmita Behera et al. Clinical Lung Cancer
- Precise Diagnosis of Intraoperative Frozen Section Is an Effective Method to Guide Resection Strategy for Peripheral Small-Sized Lung Adenocarcinoma
- (2016) Shilei Liu et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis of lung adenocarcinoma in situ and minimally invasive adenocarcinoma from intraoperative frozen sections: an analysis of 136 cases
- (2016) Ping He et al. JOURNAL OF CLINICAL PATHOLOGY
- Non-p.V600E BRAF Mutations Are Common Using a More Sensitive and Broad Detection Tool
- (2015) Jamal Carter et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Pulmonary Adenocarcinoma In Situ
- (2015) Seijiro Sato et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: accuracy and interobserver agreement
- (2015) Yi-Chen Yeh et al. HISTOPATHOLOGY
- Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma
- (2015) Shuji Murakami et al. LUNG CANCER
- Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity
- (2015) Matthew T Chang et al. NATURE BIOTECHNOLOGY
- Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA
- (2015) Evgeny Izumchenko et al. Nature Communications
- Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease
- (2014) Kyuichi Kadota et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Novel signaling axis for ROS generation during K-Ras-induced cellular transformation
- (2014) M-T Park et al. CELL DEATH AND DIFFERENTIATION
- Impact of Histologic Subtyping on Outcome in Lobar vs Sublobar Resections for Lung Cancer
- (2014) Francine R. Dembitzer et al. CHEST
- Early lung cancer with lepidic pattern
- (2014) Wilko Weichert et al. CURRENT OPINION IN PULMONARY MEDICINE
- Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis
- (2014) Shinji Sumiyoshi et al. LUNG CANCER
- Biopsy-site Changes in Lung Adenocarcinoma With Prior Core Needle Biopsy
- (2013) Erika E. Doxtader et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- EGFR and TTF-1 Gene Amplification in Surgically Resected Lung Adenocarcinomas: Clinicopathologic Significance and Effect on Response to EGFR-Tyrosine Kinase Inhibitors in Recurred Cases
- (2013) Jae Seok Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Appropriate Sublobar Resection Choice for Ground Glass Opacity-Dominant Clinical Stage IA Lung Adenocarcinoma
- (2013) Yasuhiro Tsutani et al. CHEST
- Wnt Signaling Pathway in Non-Small Cell Lung Cancer
- (2013) D. J. Stewart JNCI-Journal of the National Cancer Institute
- Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules
- (2013) Nasser K. Altorki et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations
- (2013) Koji Tsuta et al. LUNG CANCER
- HNF4α as a Marker for Invasive Mucinous Adenocarcinoma of the Lung
- (2012) Masato Sugano et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Root Cause Analysis of Problems in the Frozen Section Diagnosis of In Situ, Minimally Invasive, and Invasive Adenocarcinoma of the Lung
- (2012) Ann E. Walts et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Diagnosis of Lung Adenocarcinoma in Resected Specimens: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification
- (2012) William D. Travis et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma
- (2012) Jie Gu et al. JOURNAL OF SURGICAL ONCOLOGY
- Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study
- (2012) Erik Thunnissen et al. MODERN PATHOLOGY
- Adenocarcinomas With Prominent Lepidic Spread
- (2011) Lauren Xu et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification
- (2011) P. E. Van Schil et al. EUROPEAN RESPIRATORY JOURNAL
- Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification
- (2011) Prudence A. Russell et al. Journal of Thoracic Oncology
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- Do all lung adenocarcinomas follow a stepwise progression?
- (2011) Yasushi Yatabe et al. LUNG CANCER
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases
- (2011) Akihiko Yoshizawa et al. MODERN PATHOLOGY
- DNA Methylation Changes in Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, and Lung Adenocarcinoma
- (2011) Suhaida A. Selamat et al. PLoS One
- Limited Resection for the Treatment of Patients With Stage IA Lung Cancer
- (2010) Juan P. Wisnivesky et al. ANNALS OF SURGERY
- Stepwise progression of pulmonary adenocarcinoma—clinical and molecular implications
- (2010) Masayuki Noguchi CANCER AND METASTASIS REVIEWS
- Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis
- (2010) Moritz Bennecke et al. CANCER CELL
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Telomere Maintenance and DNA Damage Responses during Lung Carcinogenesis
- (2010) S. Lantuejoul et al. CLINICAL CANCER RESEARCH
- Epidermal Growth Factor Receptor Mutation and Pathologic-Radiologic Correlation Between Multiple Lung Nodules with Ground-Glass Opacity Differentiates Multicentric Origin from Intrapulmonary Spread
- (2010) Jin-Haeng Chung et al. Journal of Thoracic Oncology
- Histological Scoring for Small Lung Adenocarcinomas 2 cm or Less in Diameter: A Reliable Prognostic Indicator
- (2010) Akiko Miyagi Maeshima et al. Journal of Thoracic Oncology
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- Invasive Size is an Independent Predictor of Survival in Pulmonary Adenocarcinoma
- (2009) Alain C. Borczuk et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3
- (2009) Ingrid Revet et al. CANCER LETTERS
- Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
- (2009) L. M. Sholl et al. CANCER RESEARCH
- Whole Genome Comparison of Allelic Imbalance between Noninvasive and Invasive Small-Sized Lung Adenocarcinomas
- (2009) Hirofumi Nakanishi et al. CANCER RESEARCH
- CK7, CK20, CDX2 and MUC2 Immunohistochemical Staining Used To Distinguish Metastatic Colorectal Carcinoma Involving Ovary from Primary Ovarian Mucinous Adenocarcinoma
- (2009) J. H. Shin et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Epidermal Growth Factor Receptor Gene Amplification Is Acquired in Association with Tumor Progression of EGFR-Mutated Lung Cancer
- (2008) Y. Yatabe et al. CANCER RESEARCH
- Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
- (2008) J. D.F. Licchesi et al. CLINICAL CANCER RESEARCH
- Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung
- (2008) Junichi Soh et al. Journal of Thoracic Oncology
- Genomic markers for malignant progression in pulmonary adenocarcinoma with bronchioloalveolar features
- (2008) S. Aviel-Ronen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta–Notch pathway in neuroblastoma
- (2007) Ingrid Revet et al. EXPERIMENTAL CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started